biostate human coagulation factor viii 500iu/ von willebrand factor 1200iu powder for injection vial with diluent vial
csl behring australia pty ltd - von willebrand factor, quantity: 1200 iu; factor viii, quantity: 500 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
clopidogrel sanofi clopidogrel (as hydrogen sulfate) 75 mg tablet blister pack
sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate -
terry white chemists clopidogrel clopidogrel 75mg (as hydrogen sulfate) tablets blister pack
apotex pty ltd - clopidogrel hydrogen sulfate -
chemmart clopidogrel clopidogrel 75mg (as hydrogen sulfate) tablets blister pack
apotex pty ltd - clopidogrel hydrogen sulfate -
biostate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
biostate human coagulation factor viii 250iu / von willebrand factor 600iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
aristocort 0.02% ointment triamcinolone acetonide 0.2mg/g tube
aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - ointment - excipient ingredients: white soft paraffin - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.
aristocort 0.02% cream triamcinolone acetonide 0.2mg/g tube
aspen pharmacare australia pty ltd - triamcinolone acetonide, quantity: 0.2 mg/g - cream - excipient ingredients: emulsifying wax; benzyl alcohol; lactic acid; purified water; glycerol; sorbitol solution (70 per cent) (non-crystallising); isopropyl palmitate - indications as at 22 october 1998: in the treatment of the following dermatoses: atopic dermatitis, eczematous dermatitis, nummular eczema, contact dermatitis, anal and vulval pruritus, otitis externa, seborrhoeic dermatitis, exzematised psoriasis, neurodermatitis.
zatamil 0.1% ointment mometasone furoate 0.1% w/w (1 mg/g) ointment tube
ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; citric acid; light liquid paraffin; purified water; white soft paraffin; polyethylene; colloidal anhydrous silica; cetostearyl alcohol - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.
zatamil 0.1% hydrogel mometasone furoate 0.1% w/w (1 mg/g) gel tube
ego pharmaceuticals pty ltd - mometasone furoate, quantity: 1 mg/g - gel - excipient ingredients: hexylene glycol; citric acid; hypromellose; purified water - for the short term (up to four continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as psoriasis and atopic dermatitis.